A phase 2 clinical trial of pemetrexed plus gemcitabine as front-line chemotherapy for patients with malignant pleural mesothelioma (MPM).

被引：0
|
作者：
Janne, PA
Obasaju, C
Simon, G
Taub, R
Kelly, K
Fidias, P
Bloss, LP
Kindler, HL
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Lilly Oncol, Indianapolis, IN USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Univ Nacl Colombia, New York, NY USA
[5] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[6] Univ Chicago, Ctr Med, Chicago, IL USA
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7053
引用
收藏
页码：629S / 629S
页数：1
相关论文
共 50 条
  • [41] Radiological response patterns in the phase 2 STELLAR trial of TTFields with chemotherapy for first-line treatment of malignant pleural mesothelioma (MPM).
    Grosso, Federica
    Ceresoli, Giovanni Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC): A phase II clinical trial.
    McCleod, M
    Treat, J
    Christiansen, NP
    Mintzer, DM
    Bonomi, P
    Bloss, LP
    Taylor, L
    Monberg, MJ
    Ye, Z
    Obasaju, CK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 650S - 650S
  • [43] Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study
    Katirtzoglou, Nikolaos
    Gkiozos, Ioannis
    Makrilia, Nektaria
    Tsaroucha, Emilia
    Rapti, Aggeliki
    Stratakos, Grigorios
    Fountzilas, Georgios
    Syrigos, Konstantinos N.
    CLINICAL LUNG CANCER, 2010, 11 (01) : 30 - 35
  • [44] Vinorelbine as Second or Third-Line Therapy in Pemetrexed-Pretreated Malignant Pleural Mesothelioma (MPM) Patients
    Ceresoli, Giovanni L.
    Zucali, Paolo A.
    Grosso, Federica
    Mencoboni, Manlio
    Bonomi, Philip
    Parra, Hector J. M. Soto
    Pasello, Giulia
    Cortinovis, Diego
    Perrino, Matteo
    Muzio, Alberto
    Bruzzone, Andrea
    De Vincenzo, Fabio
    Degiovanni, Daniela
    Simonelli, Matteo
    Beretta, Giordano D.
    Giordano, Laura
    Santoro, Armando
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S629 - S629
  • [45] A RETROSPECTIVE ANALYSIS OF SECOND-LINE CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Bramati, A.
    Moretti, A.
    Garassino, M. C.
    Califano, R.
    Farina, G.
    Lo Dico, M.
    Cinquini, M.
    Michetti, G. N.
    Tiseo, M.
    Zucali, P. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S103 - S103
  • [46] A retrospective analysis of second-line chemotherapy for malignant pleural mesothelioma (MPM)
    La Verde, N. M.
    Bramati, A.
    Cinquini, M.
    Tiseo, M.
    Collova, E.
    Michetti, A.
    Lo Dico, M.
    Foliador, A.
    Garassino, M. C.
    Zucaii, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Vinorelbine as second or third-line therapy in pemetrexed-pretreated malignant pleural mesothelioma (MPM) patients
    Ceresoli, G. L.
    Zucali, P. A.
    Grosso, F.
    Mencoboni, M.
    Sauta, M. G.
    Soto Parra, H. J.
    Pasello, G.
    Cortinovis, D.
    Perrino, M.
    Muzio, A.
    Bruzzone, A.
    De Vincenzo, F.
    Degiovanni, D.
    Bonomi, M.
    Simonelli, M.
    Beretta, G. D.
    Giordano, L.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 77 - 77
  • [48] Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma
    Ceresoli, GL
    Zucali, PA
    Favaretto, AG
    Grossi, F
    Bidoli, P
    Del Conte, G
    Ceribelli, A
    Bearz, A
    Morenghi, E
    Cavina, R
    Marangolo, M
    Parra, HJS
    Santoro, A
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (09) : 1443 - 1448
  • [49] A phase II trial of nintedanib in recurrent malignant pleural mesothelioma (MPM).
    Wozniak, Antoinette J.
    Schneider, Bryan J.
    Kalemkerian, Gregory Peter
    Daly, Robert Michael
    Chen, Wei
    Ventimiglia, Jaclyn
    Nagasaka, Misako
    Zauderer, Marjorie Glass
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Vinorelbine (V) in pemetrexed-pretreated patients (PTS) with malignant pleural mesothelioma (MPM)
    Lorenzi, E.
    Gianoncelli, L.
    Zucali, P.
    Ceresoli, G.
    De Vincenzo, F.
    Simonelli, M.
    Ripa, C.
    Giordano, L.
    Santoro, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345